We are live on ! Find out more
NSPR icon

InspireMD

31 hedge funds and large institutions have $33.4M invested in InspireMD in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

50% more capital inflows, than outflows

Capital inflows: $2.52M | Capital outflows: $1.69M

7% more funds holding

Funds holding: 29 → 31 (+2)

0.51% more ownership

Funds ownership: 48.25% → 48.75% (+0.51%)

Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.41%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
6
Reduced
3
Closed
2
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$1K

NSPR Hedge Fund Activity: Q4 2024 in Review

31 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2024, worth a combined $33.4M — up 0.59% from $33.2M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NSPR positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Parkman Healthcare Partners, adding an estimated $2.02M. The largest seller was Nantahala Capital Management, cutting an estimated $1.44M.

  • 31 institutional investors held InspireMD (NSPR) as of Q4 2024, up from 29 in Q3 2024.
  • Funds reported $33.4M of InspireMD stock for Q4 2024, up 0.59% quarter-over-quarter.
  • 4 funds opened new InspireMD positions in Q4 2024 and 2 closed out, a net change of +2 holders.
  • The largest InspireMD buyer in Q4 2024 was Parkman Healthcare Partners, an estimated $2.02M added.
  • The largest InspireMD seller in Q4 2024 was Nantahala Capital Management, an estimated $1.44M sold.

Based on aggregated 13F filings for Q4 2024.